Twelve-Month Longitudinal Serology in SARS-CoV-2 Naïve and Experienced Vaccine Recipients and Unvaccinated COVID-19-Infected Individuals

Longitudinal data comparing SARS-CoV-2 serology in individuals following infection and vaccination over 12 months are limited. This study compared the magnitude, decay, and variability in serum IgG, IgA, and neutralizing activity induced by natural infection (<i>n</i> = 218) or mRNA vacc...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Zion Congrave-Wilson, Wesley A. Cheng, Yesun Lee, Stephanie Perez, Lauren Turner, Carolyn Jennifer Marentes Ruiz, Shirley Mendieta, Adam Skura, Jaycee Jumarang, Jennifer Del Valle, John Kubale, Emma Kaitlynn Allen, Paul G. Thomas, Aubree Gordon, Pia S. Pannaraj
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Subjects:	SARS-CoV-2 COVID-19 vaccination IgG IgA neutralizing antibodies
Online Access:	https://www.mdpi.com/2076-393X/10/5/813

Similar Items

Coronavirus Disease 2019 Vaccine Booster Effects Are Seen in Human Milk Antibody Response
by: Jeffrey M. Bender, et al.
Published: (2022-05-01)

Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals
by: Jason S. Chwa, et al.
Published: (2024-05-01)

Serological diagnosis of toxoplasmosis: usefulness of IgA detection and IgG avidity determination in a patient with a persistent IgM antibody response to Toxoplasma gondii
by: Luciana C. BERTOZZI, et al.
Published: (1999-05-01)

IgA1 dominant subclass of latent IgA mesangial deposition in donated kidney
by: Oka K, et al.
Published: (2016-11-01)

Measurement of Several Hematological and Serological Parameters in Patients with Scabies
by: Mariam Y. Al-Fadhly, et al.
Published: (2025-01-01)

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation
by: Herbert L. DuPont, et al.
Published: (2022-12-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

Differential expression of microRNAs in peripheral B lymphocytes in patients with IgA nephropathy and its clinical significance
by: WANG Qian-liao, et al.
Published: (2016-01-01)

Effect of Telitacicept on Circulating Gd-IgA1 and IgA-Containing Immune Complexes in IgA Nephropathy
by: Jincan Zan, et al.
Published: (2024-04-01)

Navigating Adult-Onset IgA Vasculitis-Associated Nephritis
by: Ming Ying Gan, et al.
Published: (2024-07-01)

Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months
by: Salma Younes, et al.
Published: (2023-11-01)

The Prevalence and Characteristics of IgA Antibodies to β2-Spectrin and CBX3 in Immunoglobulin A Nephropathy
by: Ayako Koizumi, et al.
Published: (2025-05-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

Enzyme-linked immunosorbent assay ELISA for the detection of antibodies in the human leptospirosis Teste imunoenzimático (ELISA) para detecção de anticorpos circulantes da classe IgA na leptospirose humana
by: Marcos Vinícius da Silva, et al.
Published: (1992-06-01)

Clinical and Serological Findings of COVID-19 Participants in the Region of Makkah, Saudi Arabia
by: Othman R. Alzahrani, et al.
Published: (2022-07-01)

IgM and IgA Antibody Responses in 12 Cases of Human Acquired Toxoplasmosis
by: Emília E. H. TAKAHASHI, et al.
Published: (1997-11-01)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
by: Yan-feng Zhao, et al.
Published: (2017-09-01)

Congenital toxoplasmosis: evaluation of serological methods for the detection of anti-Toxoplasma gondii IgM and IgA antibodies
by: IMX Rodrigues, et al.
Published: (2009-05-01)

Immunoglobulin Concentrations in Plasma and Saliva During the Neonatal Period
by: Sandra Pineda-Martínez, et al.
Published: (2016-06-01)

Serum IgA/C3 ratio as a diagnostic and prognostic biomarker for IgA nephropathy
by: Anitha Swamy, et al.
Published: (2025-08-01)

Study on the relationship between plasma Gd-IgA1 concentration and disease severity in IgA nephropathy and its production mechanism
by: DAI Qin, et al.
Published: (2020-01-01)

Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
by: Wencheng Xu, et al.
Published: (2023-06-01)

Rare Neurological Manifestation of Celiac Disease
by: Uzma Rani, et al.
Published: (2015-06-01)

Polyclonal Antibody Therapies for Clostridium difficile Infection
by: Michael R. Simon, et al.
Published: (2014-10-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy
by: Li Gao, et al.
Published: (2024-07-01)

Study of the antibody response against Mycobacterium tuberculosis antigens in Warao Amerindian children in Venezuela
by: Z Araujo, et al.
Published: (2004-08-01)

Changes in Immunoglobulins G and A in the Saliva and Serum of Horses with Equine Gastric Ulcer Syndrome (EGUS) and Their Relationship with Other Immune and Redox Status Biomarkers
by: María Botía, et al.
Published: (2024-11-01)

Tryptophan Attenuates the Effects of OTA on Intestinal Morphology and Local IgA/IgY Production in Broiler Chicks
by: Fernando Galdino Ricci, et al.
Published: (2020-12-01)

Frequency of specific anti-Toxoplasma gondii IgM, IgA and IgE in Colombian patients with acute and chronic ocular toxoplasmosis
by: Jorge Enrique Gómez-Marín, et al.
Published: (2000-01-01)

Intestinal immunoglobulins under microbial dysbiosis: implications in opioid-induced microbial dysbiosis
by: Nicolas Vitari, et al.
Published: (2025-04-01)

Wound Healing and Mucosal Immunity during Short Mars Analog Environment Mission: Salivary Biomarkers and Its Clinical Implications
by: Balwant Rai, et al.
Published: (2012-08-01)

Rheumatiod Factor isotype in Rheumatiod Arthritis patients .
by: Nahida R. Abbas, et al.
Published: (2007-01-01)

The level of I-FABP and IgA/IgG to beta-lactoglobulin in mothers at risk for gestational diabetes and in their children: association with antibodies to Bifidobacterium adolescentis and Bifidobacterium breve
by: Tamara Vorobjova, et al.
Published: (2025-07-01)

Prevalence of tissue transglutaminase antibodies and IgA deficiency are not increased in juvenile idiopathic arthritis: a case-control study
by: Angela Taneja Kohli, et al.
Published: (2023-10-01)

Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteria
by: Merel van Gogh, et al.
Published: (2024-10-01)

The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review
by: Hareem Farooq, MBBS, et al.
Published: (2022-02-01)

Hydroxychloroquine sulfate for IgA nephropathy: mechanisms and therapeutic potential in improving proteinuria and alleviating disease progression - a literature review
by: Liao Yilei, et al.
Published: (2025-07-01)

Significance of serum IgA/C3 ratio in the diagnosis and prognosis of IgA nephropathy
by: XIE Wei-ji, et al.
Published: (2019-01-01)

Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system
by: C Wang, et al.
Published: (2011-12-01)